The company
Halozyme Therapeutics, Inc.
HALO · Nasdaq
HALO stood above a rising 150-day average in 35 of the last 52 weekly readings, including each of the last 18 weeks. It is 46.5% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 18 in a row
- Industry in uptrend
- 18% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $83.8M
- Officials’ trades on record
- 11
- Institutions holding
- 616 (+30)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 35 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
11 disclosed lines: House 10, Senate 1, executive 0; 5 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 29 Sep 2026filed 12 Oct 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 9 Mar 2026filed 7 Apr 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 24 Mar 2025filed 7 Apr 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 9 Sep 2024filed 3 Oct 2024 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $15k–$50k | 12 Jul 2023filed 13 Aug 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 6 Dec 2022filed 13 Jan 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 5 Aug 2022filed 16 Sep 2022 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | bought | $1k–$15k | 20 Aug 2021filed 20 Sep 2021 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39 | bought | $1k–$15k | 22 Oct 2020filed 5 Nov 2020 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | bought | $1k–$15k | 19 Oct 2020filed 5 Nov 2020 |
| Mark R. Warner Senate: U.S. Senate eFDSenator | sold | $500k–$1M | 6 Nov 2017filed 8 Dec 2017 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Helen TorleyPRESIDENT AND CEO | sold | 4,810at $108.18 | 8 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 3,090at $108.91 | 8 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 11,900at $110.00 | 8 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 200at $110.51 | 8 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 8,600at $111.03 | 7 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 10,300at $111.84 | 7 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 900at $112.78 | 7 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 200at $113.69 | 7 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 2,300at $107.90 | 6 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 6,000at $109.33 | 6 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 9,920at $109.89 | 6 Oct 2026filed 8 Oct 2026 |
| Helen TorleyPRESIDENT AND CEO | sold | 1,780at $110.81 | 6 Oct 2026filed 8 Oct 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 13,271,095$1.0B | +6,0420.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 5,351,312$418.8M | +80,094+1.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 5,299,008$414.8M | +49,802+0.9% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 5,179,434$405.4M | +241,580+4.9% |
| Invesco Ltd.reduced · filed 14 Aug 2026 | 3,177,997$248.7M | -834,497−20.8% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 2,832,594$221.7M | +270,285+10.5% |
| Boston Partnersadded · filed 4 Aug 2026 | 2,773,568$216.8M | +89,885+3.3% |
| BANK OF AMERICA CORPreduced · filed 14 Aug 2026 | 2,740,561$214.5M | -172,548−5.9% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 2,519,951$197.3M | +14,165+0.6% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 2,511,050$196.5M | -14,925−0.6% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.